Development and retrospective validation of the juvenile spondyloarthritis disease activity index

Arthritis Care and Research

Volumn 66, Issue 12, 2014, Pages 1775-1782

  Weiss, Pamela F ^a   Colbert, Robert A ^b   Xiao, Rui ^a   Feudtner, Chris ^a   Beukelman, Timothy ^c   Dewitt, Esi Morgan ^d   Pagnini, Ilaria ^e   Wright, Tracey B ^f   Wallace, Carol A ^g  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Program on Child Abuse Forensic and Treatment Training   (United States)

^e UNIVERSITY OF FLORENCE   (Italy)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CLINICAL PRACTICE; CLINICAL RESEARCH; DELPHI STUDY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; ENTHESITIS; FACTORIAL ANALYSIS; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; JUVENILE ARTHRITIS DISEASE ACTIVITY SCORE; JUVENILE RHEUMATOID ARTHRITIS; JUVENILE SPONDYLOARTHRITIS DISEASE ACTIVITY INDEX; MAJOR CLINICAL STUDY; MORNING STIFFNESS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PAIN ASSESSMENT; PHYSICIAN; RETROSPECTIVE STUDY; SACROILIITIS; SPONDYLARTHRITIS; UVEITIS; VALIDATION STUDY; ADOLESCENT; FEMALE; HEALTH STATUS; MALE; PAIN MEASUREMENT; PROCEDURES; QUESTIONNAIRE; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; CHILD; DELPHI TECHNIQUE; FEMALE; HEALTH STATUS; HUMANS; MALE; PAIN MEASUREMENT; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX; SPONDYLARTHRITIS;

EID: 84912120985     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22411     Document Type: Article

References (30)

1. Reveille JD. Epidemiology of spondyloarthritis in North America. Am J Med Sci 2011;341:284-6.
2. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31: 390-2.
3. Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic diseasemodifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59:762-84.
4. Weiss P, Beukelman T, Schanberg LE, Kimura Y, Colbert R, CARRAnet Investigators. Enthesitis is a significant predictor of decreased quality of life, function, and arthritis-specific pain across juvenile arthritis (JIA) categories: preliminary analyses from the CARRAnet registry [abstract]. Arthritis Rheum 2011;63 Suppl 10:S105.
5. Boiu S, Marniga E, Bader-Meunier B, Mouy R, Compeyrot-Lacassagne S, Quartier P, et al. Functional status in severe juvenile idiopathic arthritis in the biologic treatment era: an assessment in a French paediatric rheumatology referral centre. Rheumatology (Oxford) 2012;51:1285-92.
6. Selvaag AM, Lien G, Sorskaar D, Vinje O, Forre O, Flato B. Early disease course and predictors of disability in juvenile rheumatoid arthritis and juvenile spondyloarthropathy: a 3 year prospective study. J Rheumatol 2005;32:1122-30.
7. Donnithorne KJ, Cron RQ, Beukelman T. Attainment of inactive disease status following initiation of TNF-alpha inhibitor therapy for juvenile idiopathic arthritis: enthesitis-related arthritis predicts persistent active disease. J Rheumatol 2011; 38:2675-81.
8. Otten MH, Prince FH, Twilt M, Ten Cate R, Armbrust W, Hoppenreijs EP, et al. Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis: data from the Dutch arthritis and biologicals in children register, 1999- 2010. J Rheumatol 2011;38:2258-63.
9. Flato B, Aasland A, Vinje O, Forre O. Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy. J Rheumatol 1998;25:366-75.
10. Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263-9.
11. Lukas C, Landewe R, Sieper J, Dougados M, Davis J, Braun J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:18-24.
12. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
13. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
14. Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 2009;61:658-66.
15. Horneff G, Burgos-Vargas R, Constantin T, Foeldvari I, Vojinovic J, Chasnyk VG, et al. Efficacy and safety of openlabel etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study. Ann Rheum Dis 2013;73:1114-22.
16. Burgos-Vargas R, Vazquez-Mellado J, Pacheco-Tena C, Hernandez-Garduno A, Goycochea-Robles MV. A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies. Ann Rheum Dis 2002;61:941-2.
17. Wallace CA, Ruperto N, Giannini E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004;31:2290-4.
18. Juniper EF, Guyatt GH, Streiner DL, King DR. Clinical impact versus factor analysis for quality of life questionnaire construction. J Clin Epidemiol 1997;50:233-8.
19. Boers M, Brooks P, Strand CV, Tugwell P. The OMERACT filter for Outcome Measures in Rheumatology. J Rheumatol 1998;25:198-9.
20. Wallace CA, Ravelli A, Huang B, Giannini EH. Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis. J Rheumatol 2006;33:789-95.
21. Iglesias MJ, Cuttica RJ, Herrera Calvo M, Micelotta M, Pringe A, Brusco MI. Design and validation of a new scale to assess the functional ability in children with juvenile idiopathic arthritis (JIA). Clin Exp Rheumatol 2006;24:713-8.
22. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
23. Sieper J, van der Heijde D, Landewe R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis International Society (ASAS). Ann Rheum Dis 2009;68: 784-8.
24. McErlane F, Beresford MW, Baildam EM, Chieng SE, Davidson JE, Foster HE, et al. Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis. Ann Rheum Dis 2012; 72:1983-8.
25. Woolston SL, Beukelman T, Sherry DD. Back mobility and interincisor distance ranges in racially diverse North American healthy children and relationship to generalized hypermobility. Pediatr Rheumatol Online J 2012;10:17.
26. Classification and Response Criteria Subcommittee of the American College of Rheumatology Committee on Quality Measures: development of classification and response criteria for rheumatic diseases. Arthritis Rheum 2006;55:348-52.
27. Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Cheang M. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol 2002;29: 1989-99.
28. Oen K, Tucker L, Huber AM, Miettunen P, Scuccimarri R, Campillo S, et al. Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study. Arthritis Rheum 2009;61:1077-86.
29. Zak M, Pedersen FK. Juvenile chronic arthritis into adulthood: a long-term follow-up study. Rheumatology (Oxford) 2000;39:198-204.
30. Minden K, Kiessling U, Listing J, Niewerth M, Doring E, Meincke J, et al. Prognosis of patients with juvenile chronic arthritis and juvenile spondyloarthropathy. J Rheumatol 2000;27:2256-63.